L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles

Small. 2016 Jan 20;12(3):301-6. doi: 10.1002/smll.201502545. Epub 2015 Nov 30.

Abstract

Manganese oxide nanoparticles (MONPs) are capable of time-dependent magnetic resonance imaging contrast switching as well as releasing a surface-bound drug. MONPs give T2/T2* contrast, but dissolve and release T1-active Mn(2+) and L-3,4-dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.

Keywords: MRI; contrast agents; drug delivery; l-DOPA; manganese; manganese oxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coated Materials, Biocompatible / chemistry*
  • Contrast Media / chemistry*
  • Drug Delivery Systems / methods*
  • Levodopa / pharmacology*
  • Magnetic Resonance Imaging / methods*
  • Manganese Compounds / chemistry*
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Oxides / chemistry*
  • Rats
  • Sus scrofa
  • Water / chemistry

Substances

  • Coated Materials, Biocompatible
  • Contrast Media
  • Manganese Compounds
  • Oxides
  • Water
  • Levodopa
  • manganese oxide